Acidophilus

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acidophilus

What is Acidophilus?

Acidophilus, formally known as Lactobacillus acidophilus, is a species of gram-positive, rod-shaped bacteria. It is one of the most common types of probiotics—microorganisms that are intended to provide health benefits when consumed or applied to the body.

Natural Occurrence and Biological Role

These bacteria occur naturally in the human body, primarily residing in the gastrointestinal tract, the mouth, and the vaginal canal. As a member of the lactic acid bacteria group, acidophilus plays a functional role in the ecosystem of the human microbiome. It breaks down sugars, such as lactose, into lactic acid. This process helps maintain an acidic environment, which can influence the balance of the local microbial population.

Commercial and Dietary Sources

Outside of the human body, acidophilus is frequently used in the food industry and as a dietary supplement. It is often added to dairy products to assist in fermentation and to enhance the probiotic content of the food. Common sources include:

  • Fermented dairy: Yogurt, kefir, and certain types of cheese.
  • Fortified foods: Juices or cereals that have been enriched with live cultures.
  • Supplements: Available in various forms such as capsules, tablets, liquids, and powders.

Mechanism of Action

Acidophilus functions by colonizing specific areas of the body and competing with other microorganisms for nutrients and attachment sites on the mucosal linings. By producing lactic acid and other substances, it creates a physiological environment that supports the maintenance of a normal, healthy flora.

Regulatory References

  1. NIH Probiotics Fact Sheet
  2. FAO/WHO Guidelines for Probiotics

What side effects are possible with Acidophilus?

Possible Side Effects and Safety Information

Side effects associated with Acidophilus (Lactobacillus acidophilus) are generally mild and primarily affect the gastrointestinal system. Common, less severe reactions include bloating, gas, and increased flatulence. While these typically do not require medical intervention, their frequency is not consistently categorized across formal regulatory documents.


Serious Adverse Reactions and Safety Restrictions

Serious adverse reactions, though considered rare, have been documented and are a key safety concern in vulnerable populations. These include serious systemic infections such as bacteremia or sepsis, which may be fatal. These infections are caused by the live microorganisms and have been reported, particularly in premature infants in hospital settings and individuals with compromised immune systems.

Population-specific safety considerations and restrictions apply:

  • Individuals with Weakened Immune Systems: Persons with HIV/AIDS, those undergoing chemotherapy, critical illness, or taking immunosuppressants are at a greater risk of infection from probiotic use and should exercise caution.
  • Central Lines and Structural Heart Disease: Patients with central venous catheters, scarred liver (cirrhosis), or damaged heart valves have an increased susceptibility to infection.
  • Preterm Infants: The U.S. Food and Drug Administration (FDA) has issued warnings regarding the risk of invasive disease in preterm infants given probiotic products containing live bacteria or yeast.

General Safety Notes

As a dietary ingredient, Lactobacillus acidophilus often holds a Generally Recognized As Safe (GRAS) status for use in food; however, the FDA has not approved any probiotic product for use as a drug to treat or prevent a disease in infants, highlighting a lack of premarket evaluation for safety and effectiveness in this use. Taking products containing live bacteria simultaneously with antibiotics may reduce the effectiveness of the Acidophilus strain; a time separation of at least two to three hours is generally noted.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for products containing Lactobacillus acidophilus (Acidophilus) do not define a classic toxicological overdose profile. Due to the product’s classification as a probiotic, acute toxicity in the manner of a conventional chemical drug is not expected in otherwise healthy individuals. Excessive consumption may, however, increase the likelihood of minor gastrointestinal effects such as abdominal discomfort and passing gas.

The critical regulatory concern centers on the risk of severe adverse events. The most serious, life-threatening risk documented by health authorities is the potential for the live bacteria to cause an invasive infection (e.g., sepsis), particularly in highly vulnerable patients. This specific risk has led the FDA to issue warnings concerning use in preterm infants and immunocompromised individuals who are at elevated risk.

Overdose Context Immediate Action Required (Regulator Mandated)
Signs of Serious Infection (e.g., fever, chills, persistent sore throat) Contact a healthcare professional immediately.
Signs of Severe Allergic Reaction (e.g., swelling, trouble breathing, fast heartbeat, dizziness) Seek immediate medical attention or call emergency services.

Overdose management is generally limited to symptomatic and supportive treatment; no specific antidote is documented in official labeling. Hospital monitoring may be required for patients presenting with signs of serious infection.

Therapeutic Uses of Acidophilus

Main Uses and Benefits of Acidophilus

Lactobacillus acidophilus is a type of bacteria that exists naturally in the human body, primarily within the digestive tract and the vaginal canal. As a probiotic, it is used to support the maintenance of a healthy balance of microflora.

Digestive Health and Restoration

The primary use of acidophilus is to support gastrointestinal function. It is frequently utilized to address imbalances in the gut microbiome, which can occur due to illness or certain lifestyle factors. By colonizing the intestinal walls, these beneficial bacteria help maintain an environment that is less hospitable to potentially harmful microorganisms.

  • Diarrhea Management: Acidophilus is often used to help manage various forms of diarrhea, including traveler’s diarrhea and issues related to rotavirus.
  • Antibiotic-Associated Flora Support: During and after a course of antibiotics, the natural bacterial population in the gut can be significantly depleted. Acidophilus is commonly used to replenish these beneficial bacteria and reduce the gastrointestinal side effects often associated with antibiotic use.
  • Irritable Bowel Syndrome (IBS): Some individuals use acidophilus to help manage symptoms associated with IBS, such as abdominal pain, bloating, and irregular bowel movements.

Vaginal Health

In the vaginal ecosystem, acidophilus plays a critical role in maintaining an acidic environment. This acidity is essential for preventing the overgrowth of organisms that can lead to imbalances. It is frequently used to support the recovery and maintenance of healthy vaginal flora.

Lactose Digestion

Acidophilus produces lactase, an enzyme required to break down lactose (the sugar found in milk). For individuals with lactose intolerance, acidophilus may assist in the digestion of dairy products, potentially reducing symptoms like gas and cramping.

Immune System Support

A significant portion of the human immune system is located within the digestive tract. By promoting a stable and healthy intestinal environment, acidophilus may contribute to the overall efficiency of the body's natural defenses.

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Acidophilus

Regulatory information defines population eligibility for Lactobacillus acidophilus products primarily through contraindications related to immune status and age-group data limitations.

Contraindicated and Restricted Populations

Classification Population Restriction
Contraindicated Individuals with known hypersensitivity or allergy to the active substance or excipients.
Contraindicated Hospitalized preterm infants (due to specific warnings against live microbial products).
Use with Caution Immunocompromised patients or those with a central venous catheter (CVC) due to risk of systemic infection.
Use with Caution Individuals with severe underlying or critical illness.

Age-Specific and Conditional Eligibility

Use in the general adult population is generally permitted unless the individual falls into a restricted category. However, eligibility is often classified as "not established" for both the pediatric (children and infants) and geriatric (older adult) populations due to insufficient official regulatory data.

For pregnancy and breastfeeding, eligibility is conditional. Official labeling often notes the lack of adequate or well-controlled studies in these groups, advising consultation prior to use to weigh potential benefits against unknown risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acidophilus (Lactobacillus acidophilus), a live biotherapeutic product, possesses an official interaction profile focused on maintaining the viability of its cultures, rather than systemic metabolic effects documented for chemical drugs. Regulatory documentation does not list any formal contraindicated combinations or pharmacokinetic (CYP enzyme or transporter) interactions, as the product is not absorbed into the bloodstream.

The most significant official interaction is pharmacodynamic antagonism with antibacterial medicinal products, such as antibiotics. Co-administration of Acidophilus with these agents may lead to the inactivation or destruction of the viable bacterial cultures, compromising the product’s intended effect. To manage this risk, official labeling mandates a timing separation requirement.

Official Interaction Constraints

Interaction Type Requirement/Restriction
Antibacterial Agents Must be administered 2 to 4 hours before or after the antibiotic dose.
Food/Substance Restriction Ingestion with alcohol or extremely hot or highly acidic beverages may compromise bacterial viability.

This structure reflects official government regulatory guidance for probiotics, which focuses on the procedural constraints necessary to ensure the active ingredient remains intact and functional within the gastrointestinal tract.

Mechanism of Action

How Lactobacillus acidophilus Works

The mechanism of action for Lactobacillus acidophilus is defined by its role as a viable biological agent that modulates the intestinal environment and host physiology through distinct local processes, rather than by targeted chemical inhibition or agonism. The core function is to influence pathways that regulate gastrointestinal homeostasis.


Competitive Exclusion and Biochemical Antagonism

This mechanistic domain involves the direct physical and chemical antagonism against competing microorganisms. L. acidophilus binds to the intestinal epithelial cells, physically blocking adhesion sites required by opportunistic bacteria (competitive exclusion). Simultaneously, it utilizes metabolic processes to produce lactic acid and bacteriocins, leading to a local pH drop and the creation of an environment unfavorable to the survival of many pathogens. This biological control directly results in the adjustment of the microbial community structure.


️ Barrier Reinforcement and Immune Signaling Modulation

This domain addresses the organism's influence on the host's tissue and defense systems. Components of L. acidophilus reinforce the integrity of the intestinal barrier by modulating the expression of tight junction proteins in the gut lining. Furthermore, the bacteria interact with Toll-Like Receptors (TLRs) on immune cells in the GALT, influencing signaling cascades such as NF-kappa B to drive the adjustment of inflammatory signaling within the intestinal mucosa. These actions influence local physiological signaling in the gut.

Dosage and Administration Information

How to Use Acidophilus: Official Administration Guidelines

Administration of Lactobacillus acidophilus products is organized according to parameters that define the route, dosage, and timing. The approved route is primarily oral, with some specific products utilizing the intravaginal route. Dosing is standardized by Colony Forming Units (CFU), rather than weight. The typical adult dosage range is broad, frequently falling between 1 imes 10^9 CFU and 1 imes 10^11 CFU per day, often administered as one to two unit doses daily.


Official Usage Patterns

The most common frequency pattern is once daily, although a regimen of divided use (two to four times daily) may be used to achieve a higher total CFU intake.

Administration Constraint Official Instruction
Timing with Food Generally taken with or without food.
Antibiotic Interval Must be taken a minimum of 2 hours before or after an antibiotic dose to ensure bacterial viability.
Enteric-Coated Forms Swallow whole; must not be chewed or crushed to protect the bacteria from stomach acid.

Use Over Time and Special Handling

Usage patterns vary, including short-term courses (e.g., 5 to 7 days) often linked to specific events, or longer-term use extending up to 12 weeks for ongoing supportive care. For pediatric patients, particularly those under 3 years of age, administration and dosing must be determined under medical supervision. If a dose is missed, it is generally recommended to skip the missed dose and resume the regular schedule, with strict instruction not to double the dose. These instructions are intended to ensure the product is used in a consistent and predictable manner.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acidophilus

Evidence for use in Antibiotic-Associated Diarrhea (AAD)

Research has explored whether the use of Lactobacillus acidophilus during antibiotic therapy is associated with the risk of diarrhea. The primary research available for this context consists of Randomized Controlled Trials (RCTs) and systematic overviews known as meta-analyses, which combine results from multiple smaller studies. Studies monitored how symptoms evolved in the observed populations, and findings describe patterns observed in the studies where the group receiving the probiotic was associated with a lower reported rate of diarrhea in the studied antibiotic-using population.

What remains uncertain is the specific and consistent effect of the L. acidophilus strain alone, independent of other probiotics often included in the treatment. Data characterizing the single-strain effect remain limited due to differences in antibiotic types and probiotic dosing. Furthermore, follow-up durations were limited, meaning that long-term effects are not fully established regarding the durability of effects related to intestinal stability.


Evidence for use in Acute Infectious Diarrhea

The clinical context of acute or disruptive episodes of diarrhea was studied for how symptoms evolved in the observed populations following the use of Lactobacillus acidophilus. The evidence relies heavily on Randomized Controlled Trials (RCTs), with the majority of studies focusing on children. Research primarily examined short-term symptom changes, monitoring outcomes such as the duration of diarrhea and the frequency of stools.

Studies report how symptoms evolved in the observed populations, and findings describe patterns observed where the probiotic studies reported an association with a shorter duration of diarrhea, particularly in pediatric populations. However, evidence remains limited and findings were mixed when trying to draw broad conclusions across all causes of acute diarrhea or all age groups. Comparative evidence regarding other interventions for temporary physiological imbalance is scarce.


Evidence for use in Irritable Bowel Syndrome (IBS) Symptom Management

Lactobacillus acidophilus was evaluated in studies focused on the management of symptoms associated with chronic conditions characterized by fluctuating or episodic manifestations, such as Irritable Bowel Syndrome (IBS). Randomized Controlled Trials (RCTs) are the central study design, examining patient-reported experiences of outcomes related to physical discomfort, like abdominal pain intensity and bloating, in adults diagnosed with IBS. There is limited information for long-term outcomes regarding whether any observed symptomatic changes are durable beyond the intermediate follow-up period.

Key Studies & References

  1. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis
  2. Guidelines for the Evaluation of Probiotics in Food (FAO/WHO Working Group Report)

Frequently Asked Questions (FAQ)

Common questions about Acidophilus (FAQ)


Q: Do I need a prescription to buy Acidophilus?

Most Acidophilus products are classified as dietary supplements or food ingredients in many regions, including the US. This regulatory classification indicates that the product is generally available over-the-counter and does not require a prescription from a healthcare professional.


Q: Is Acidophilus the same as yogurt?

No, they are not the same. While the Lactobacillus acidophilus bacteria may be naturally present in fermented foods like yogurt, therapeutic Acidophilus supplements are different. Supplements are manufactured to contain standardized, quantified, and stable amounts of the specific viable bacteria, which is distinct from the varying content found in food products.


Q: What is the difference between Acidophilus and other common probiotics like Bifidus?

Acidophilus (Lactobacillus acidophilus) and Bifidus (Bifidobacterium) belong to different genuses (groups) of bacteria. Official regulatory and scientific documentation recognizes that different species and strains of probiotics have their own unique biological characteristics. These distinctions reflect the different biological activities that may be observed for each group.


Q: Is it normal to have mild gas when starting Acidophilus?

Official safety documents list gas, bloating, and flatulence as common, generally mild, gastrointestinal side effects. These reactions are observed and usually considered mild. They are generally self-limiting, consistent with a live biological agent.


Q: Does Acidophilus interact with birth control pills?

Official labeling documentation does not list oral contraceptives as a specific drug interaction. Because the product is a live biological agent that primarily acts in the gut and is not absorbed systemically into the bloodstream, major interaction warnings focus on maintaining the viability of the bacteria.


Q: Why might a doctor suggest Acidophilus to a patient?

Health professionals may discuss the use of Acidophilus to support the balance of microorganisms in the gut. This is often in the context of antibiotic use, where maintaining gut flora balance is a common consideration described in regulatory summaries.


Q: Can Acidophilus interact with vitamins or supplements?

Official regulatory summaries do not report known major interactions between Acidophilus and common vitamins or mineral supplements. The primary interaction warnings are focused on the need to separate the timing of its use from antibacterial medicinal products.


Q: Why might Acidophilus cause gas or bloating in some users?

The mechanism for gas and bloating is linked to the active nature of the bacteria. As the live bacteria begin to consume carbohydrates in the intestine, they may produce gases such as hydrogen or carbon dioxide through a natural process called fermentation. This can lead to the sensation of increased gas.


Q: Why is Acidophilus often found in fermented foods?

Acidophilus is a specific type of lactic acid bacteria (LAB). These bacteria are naturally used in traditional food fermentation processes for products like certain dairy items, where they help create the characteristic flavors and textures. This natural role aligns with its use as a probiotic ingredient.


Q: Is the Acidophilus strain L. acidophilus NCFM different from other L. acidophilus types?

Yes. While they belong to the same species, regulatory guidance often controls probiotic ingredients at the strain level. Different strains (e.g., NCFM) are distinct in their genotype and specific characteristics and may have been researched for different biological activities.


Q: Does Acidophilus need to be refrigerated?

Official regulatory information typically specifies storage at Controlled Room Temperature (about 15 C to 30 C), protected from heat and direct light. Some specific product labels may require refrigeration after opening to best preserve the viable bacteria, but this is not a universal requirement.


Q: Can Acidophilus help with occasional diarrhea?

Research has focused primarily on the use of Acidophilus in specific contexts, such as Antibiotic-Associated Diarrhea and Acute Infectious Diarrhea (often in children). The evidence themes describe associations with changes in symptoms only within these specific studied populations.


Q: Do people with allergies need to be careful with Acidophilus?

Yes. Official safety information advises caution for individuals with a known hypersensitivity or allergy to the active substance or to any of the non-active ingredients (excipients) used in the product preparation. Reviewing the product label for common allergens like lactose or soy is consistent with general regulatory guidance.


Q: Are there specific instructions for stopping Acidophilus?

Official regulatory documents do not typically provide specific instructions for stopping a course of use. Instructions often focus on resuming the regular schedule if a dose is missed. If side effects persist or become severe, contacting a healthcare professional for guidance is the appropriate course of action.


Q: Is Acidophilus a medically approved drug or a dietary supplement?

Most Acidophilus products in regions like the US are regulated as dietary supplements or food ingredients. Regulatory bodies have noted they have not approved the product as a drug to prevent or treat disease in specific vulnerable populations, such as infants.


Q: Does Acidophilus interact with alcohol?

The official guidance advises that ingestion with alcohol may compromise the viability of the live bacterial cultures. This potential destruction of the active ingredient would reduce the product's intended effect on the gut flora.


Q: Is it better to take a high-dose or low-dose Acidophilus product?

Regulatory guidance provides a typical dosage range measured in Colony Forming Units (CFU). Scientific studies have examined different doses of the same strain and found that the amount of the active ingredient may influence its observed biological effects. Official guidance and research do not identify a single 'better' dose, as the effect may vary based on the specific strain and CFU count.

How should Acidophilus be stored and disposed of?

Official Storage and Disposal Requirements

Storage Conditions

Requirement Official Regulatory Statement
Temperature Range Store at Controlled Room Temperature (15 C to 30 C or 59 F to 86 F) [DailyMed - NIH].
Prohibited Conditions DO NOT FREEZE and keep away from heat and direct light [DailyMed - NIH, Mayo Clinic].
Post-Opening/Container Keep container closed in a cool, dry place. Some labels require storing in the Refrigerator after opening [DailyMed - NIH].

Disposal and Child Safety

The product must be kept out of the reach of children. Regarding disposal, users must not keep outdated medicine or medicine no longer needed. The official instruction is to Ask your healthcare professional how you should dispose of any medicine you do not use to ensure compliance with local regulations [Mayo Clinic].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acidophilus found in:

A-Z Index: